The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification
Related Experiment Video
Updated: Jun 2, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Annie Moisan1, Miguel N Rivera1,2, Sutada Lotinun3
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
Abstract:
WTX is an X-linked tumor suppressor targeted by somatic mutations in Wilms tumor, a pediatric kidney cancer, and by germline inactivation in osteopathia striata with cranial sclerosis, a bone overgrowth syndrome. Here, we show that Wtx deletion in mice causes neonatal lethality, somatic overgrowth, and malformation of multiple mesenchyme-derived tissues, including bone, fat, kidney, heart, and spleen. Inactivation of Wtx at different developmental stages and in primary mesenchymal progenitor cells (MPCs) reveals that bone mass increase and adipose tissue deficiency are due to altered lineage fate decisions coupled with delayed terminal differentiation. Specification defects in MPCs result from aberrant β-catenin activation, whereas alternative pathways contribute to the subsequently delayed differentiation of lineage-restricted cells. Thus, Wtx is a regulator of MPC commitment and differentiation with stage-specific functions in inhibiting canonical Wnt signaling. Furthermore, the constellation of anomalies in Wtx null mice suggests that this tumor suppressor broadly regulates MPCs in multiple tissues.
Insights
WTX, a tumor suppressor, regulates mesenchymal progenitor cells (MPCs) and their differentiation. Its absence causes developmental defects and overgrowth, highlighting its crucial role in multiple tissues.
Area of Science:
- Developmental Biology
- Cancer Biology
- Genetics
Background:
- WTX is an X-linked tumor suppressor implicated in Wilms tumor and osteopathia striata with cranial sclerosis.
- Somatic mutations and germline inactivation of WTX are linked to specific diseases.
Purpose of the Study:
- To investigate the function of WTX in mesenchymal progenitor cell (MPC) development and differentiation.
- To elucidate the mechanisms by which WTX regulates tissue development and prevents overgrowth.
Main Methods:
- Gene deletion studies in mice to assess WTX function.
- Analysis of primary mesenchymal progenitor cells (MPCs) from WTX-deficient models.
- Investigation of signaling pathways, including Wnt/β-catenin, involved in MPCs.
Main Results:
- WTX deletion in mice leads to neonatal lethality, somatic overgrowth, and malformations in multiple mesenchyme-derived tissues.
- Altered lineage fate decisions and delayed differentiation in MPCs contribute to increased bone mass and reduced adipose tissue.
- Aberrant β-catenin activation in MPCs underlies specification defects, with other pathways involved in delayed differentiation.
Conclusions:
- WTX is a critical regulator of MPC commitment and differentiation with stage-specific roles.
- WTX acts by inhibiting canonical Wnt signaling during MPC development.
- The findings suggest WTX broadly regulates MPCs across various tissues, acting as a key tumor suppressor.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Non-Canonical Wnt Signaling Pathways